“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals”. Journal of Pharmaceutical Negative Results, Nov. 2022, pp. 921-9, https://www.pnrjournal.com/index.php/home/article/view/3403.